{"id":16536,"date":"2013-02-15T00:00:00","date_gmt":"2013-02-15T05:00:00","guid":{"rendered":"https:\/\/genomequebec.com\/actualites-et-publications\/launch-of-the-personalized-medicine-partnership-for-cancer\/"},"modified":"2013-02-15T00:00:00","modified_gmt":"2013-02-15T05:00:00","slug":"launch-of-the-personalized-medicine-partnership-for-cancer","status":"publish","type":"post","link":"https:\/\/genomequebec.com\/en\/news-and-publications\/launch-of-the-personalized-medicine-partnership-for-cancer\/","title":{"rendered":"Launch of the Personalized Medicine Partnership for Cancer"},"content":{"rendered":"<p>The Government of Qu\u00e9bec announced today an investment in the Personalized Medicine Partnership for Cancer (PMPC).\u00a0The PMPC will be under the leadership of Caprion Proteome Inc., a Montreal-based biotech company specializing in the discovery and development of protein-based diagnostic biomarkers.<\/p>\n<p><span id=\"result_box\" lang=\"en\"><span class=\"hps\">G\u00e9nome<\/span> <span class=\"hps\">Qu\u00e9bec congratulates<\/span> <span class=\"hps\">Martin<\/span> <span class=\"hps\">LeBlanc<\/span><span>, President and Chief<\/span> <span class=\"hps\">Executive Officer of<\/span> <span class=\"hps\">Caprion<\/span> <span class=\"hps\">Proteomics<\/span><span>, who is<\/span> <span class=\"hps\">the head of this<\/span> <span class=\"hps\">public-private partnership<\/span> <span class=\"hps\">with a total value<\/span> <span class=\"hps\">of<\/span> <span class=\"hps\">$ 21.1 million<\/span><span>.<\/span><\/span><\/p>\n<p><span lang=\"en\"><span>For more information, <a href=\"http:\/\/www.newswire.ca\/en\/story\/1115257\/investment-in-a-quebec-public-private-partnership-to-support-the-use-of-personalized-medicine-solutions-in-the-treatment-of-cancer-patients\" target=\"_blank\" rel=\"noopener\">click here<\/a>.<br \/><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Government of Qu\u00e9bec announced today an investment in the Personalized Medicine Partnership for Cancer (PMPC).\u00a0The PMPC will be under the leadership of Caprion Proteome Inc., a Montreal-based biotech company&hellip;<\/p>\n","protected":false},"author":1,"featured_media":15330,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[294],"tags":[],"class_list":["post-16536","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles"],"acf":[],"_links":{"self":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/16536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/comments?post=16536"}],"version-history":[{"count":0,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/16536\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media\/15330"}],"wp:attachment":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media?parent=16536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/categories?post=16536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/tags?post=16536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}